Bill Would Expand Iowa’s Medical Cannabis Program To Include Flower Products

Iowa lawmakers advanced House Study Bill 532

Iowa medical cannabis manufacturers told Iowa lawmakers Tuesday that allowing the sale of raw cannabis flowers in the state’s medical cannabidiol program would reduce costs for patients.

But representatives of state agencies who spoke at a House subcommittee meeting said the change could cause problems for law enforcement and safety on state roads

Iowa lawmakers advanced House Study Bill 532 through a three-member subcommittee Tuesday. The bill would change Iowa’s definition of “medical cannabidiol” to include forms of oral, topical and inhalable cannabis — including raw cannabis flower.

Dane Schumann, a lobbyist with MedPharm Iowa, one of the firms licensed to manufacture medical marijuana in the state, said the current Iowa Code requires medical cannabis products to be extracts. That means manufacturers grow marijuana plants, extract the active compounds known as CBD and THC from those crops and create a new product to sell for use through the medical cannabis program.

To Read The Rest Of This Article On Iowa Capital Dispatch, Click Here

Stay up-to-date!

Get all the news and info straight into your inbox that you need to help grow your business.

Marijuana Retail Report, is a national daily online trade publication serving retailers of marijuana products and accessories. News and information are geared strictly to select retail channels, with distribution limited to licensed collectives, recreational retailers, accessories retailers, and wholesalers.


Stay informed with the most up-to-date industry news to help you grow your business: subscribe to our newsletter below!

To Top